Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

Plant regeneration relies on a delicate balance between stem cell renewal and differentiation, yet the evolutionary origin ...

Celltrion outlines a blueprint for innovative drug development built on its antibody expertiseThe company highlights its ...

Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf," cell therapies for serious medical conditions, ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...

New wireless carriers show how retail consumer segmentation is shifting toward identity, behavior, trust, and affiliation, ...

Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is ...

After years of enthusiasm around alternative proteins, cellular agriculture startups are facing a far more sobering capital ...

By editing thousands of genes in mouse stem cells, the scientists identified a list of over 300 that are crucial for neural differentiation.